Validity of plasma remnant lipoproteins as surrogate markers of antemortem level in cases of sudden coronary death

Clinica Chimica Acta

Volumn 343, Issue 1-2, 2004, Pages 93-103

  Takeichi, Sanae ^a   Nakajima, Yasuhiro ^a   Yukawa, Nobuhiro ^a   Fujita, Masaki Q ^a   Saito, Takeshi ^a   Satoh, Fumiko ^a   Seto, Yoshihisa ^a   Kusakabe, Takahiko ^a   Jin, Zheng Bin ^a   Hasegawa, Iwao ^a   Nakano, Takamitsu ^b   Saniabadi, Abby ^b   Adachi, Masakazu ^b   Ohara, Naoki ^c   Usui, Shinichi ^d   Okazaki, Mitsuyo ^d   Nakajima, Katsuyuki ^b  

^a TOKAI UNIVERSITY   (Japan)

^b JAPAN IMMUNORESEARCH LABORATORIES   (Japan)

^c HATANO RESEARCH INSTITUTE   (Japan)

^d Tokyo Medical and Dental University ^*  (Japan)

Author keywords

Free glycerol; HPLC; Postmortem plasma; Remnant lipoproteins; Sudden coronary death; Triglycerides

Indexed keywords

LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; AUTOPSY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE MARKER; EXPERIMENTAL MODEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PLASMA; PRIORITY JOURNAL; RABBIT; SUDDEN DEATH;

ADULT; AGED; ANIMALS; BIOLOGICAL MARKERS; CHOLESTEROL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; POSTMORTEM CHANGES; RABBITS; REPRODUCIBILITY OF RESULTS; TRIGLYCERIDES;

ORYCTOLAGUS CUNICULUS;

EID: 11144357860     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2003.12.031     Document Type: Article

References (38)

1. Glanville J.N. Postmortem serum cholesterol levels. Br. Med. J. 12:1960;1852-1853
2. Särkioja T., Ylä-Herttuala S., Solakivi T., Nikkari T., Hirvonen J. Stability of plasma total cholesterol, triglycerides and apolipoprotein B and A-I during the early postmortem period. J. Forensic Sci. 33:1988;1432-1438
3. Horick C.A., Baker H.N., Malcom G.T., Newman W.P., Roheim P.S., Strong J.P. Lipoproteins and apolipoproteins in postmortem serum. Mod. Pathol. 1:1988;480-484
4. Enticknap J.B. Lipids in cadaver sera after fatal heart attacks. J. Clin. Pathol. 12:1961;496-499
5. Fekete J.F., Brunsdon D.F.V. The use of routine laboratory tests in postmortem examinations. Can. Soc. Forensic Sci. 7:1974;238-254
6. Freedman D.S., Wattigney W.A., Srinivasan S., Newman W.P. III, Tracy R.E., Byers T., et al. The relation of atherosclerotic lesions to antemortem and postmortem lipid levels: the Bogalusa Heart Study. Atherosclerosis. 104:1993;37-46
7. Tsuji A., Ikeda N., Kojimahara M., Takeichi S. Forensic application of biochemical blood analysis - experimental studies of postmortem changes of value in cadaveric blood. Res. Pract. Forensic Med. 36:1993;97-103. [in Japanese with English summary]
8. Hiserodt J.C., Perper J.A., Koehler S.A., Orchard T.J. A composition of lipid and lipoprotein values in young adults who die suddenly and unexpectedly from atherosclerotic coronary artery disease. Am. J. Forensic Med. Pathol. 16:1995;101-106
9. Takeichi S., Nakajima Y., Osawa M., Yukawa N., Saito T., Seto Y., et al. The possible role of remnant-like particles as a risk factor for sudden cardiac death. Int. J. Legal Med. 110:1997;213-219
10. Takeichi S., Yukawa N., Nakajima Y., Osawa M., Saito T., Seto Y., et al. Association of plasma triglyceride-rich lipoprotein remnants with coronary artery atherosclerosis in cases of sudden cardiac death. Atherosclerosis. 142:1999;309-315
11. Campos E., Nakajima K., Tanaka A., Havel R.J. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody B-100. J. Lipid Res. 33:1992;369-380
12. Nakajima K., Saito T., Tamura A., Suzuki M., Nakano T., Adachi M., et al. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. Clin. Chim. Acta. 223:1993;53-71
13. Marcoux C., Tremblay M., Fredenrich A., Jacques H., Krimbou L., Nakajima K. Plasma remnant-like particle lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects. Atherosclerosis. 139:1998;161-171
14. Marcoux C., Tremblay M., Nakajima K., Davignon J., Cohn J.S. Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipidemic patients. J. Lipid Res. 40:1999;636-647
15. Tomono S., Kawazu S., Kato N., Ono T., Ishii C., Ito Y., et al. Uptake of remnant like particles (RLP) in diabetic patients by mouse peritoneal macrophage. J. Atheroscler. Thromb. 1:1994;98-102
16. Knöfler R., Nakano T., Nakajima K., Takada Y., Takada A. Remnant-like lipoproteins stimulate whole blood platelet aggregation in vitro. Thromb. Res. 78:1995;161-171
17. Saniabadi A.R., Umemura K., Shimoyama M., Adachi M., Nakano M., Nakashima M. Aggregation of human blood platelets by remnant-like lipoprotein particles of plasma chylomicrons and very low density lipoproteins. Thromb. Haemost. 77:1997;996-1001
18. Doi H., Kugiyama K., Ohgushi M., Sugiyama S., Matsushita T., Ohta Y., et al. Remnants of chylomicron and very low-density lipoprotein impair endothelium-dependent vasorelaxation. Atherosclerosis. 137:1998;341-349
19. Kugiyama K., Doi H., Motoyama T., Soejima H., Misumi K., Kawano H., et al. Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries. Circulation. 97:1998;2519-2526
20. Doi H., Kugiyama K., Ohgushi M., Sugiyama S., Matsumura T., Ohta Y., et al. Membrane active lipids in remnant lipoproteins cause impairment of endothelium-dependent vasorelaxation. Arterioscler Thromb. Vasc. Biol. 19:1999;1918-1924
21. Nakajima K., Okazaki M., Tanaka A. Separation and determination of remnant-like particles in serum from diabetes patients using monoclonal antibodies to apo B-100 and apo A-I. J. Clin. Ligand Assay. 19:1996;177-183
22. McNamara J.R., Shah P.K., Nakajima K., Cupples L.A., Wilson P.W., Ordavas J.M., et al. Remnant lipoprotein cholesterol and triglyceride reference ranges from the Framingham Heart Study. Clin. Chem. 44:1998;1224-1232
23. Sakata K., Miho N., Shirotani M., Yoshida H., Takada Y., Takada A. Remnant-like particle cholesterol is a major risk factor for myocardial infarction in vasospastic angina with nearly normal coronary artery. Atherosclerosis. 136:1998;225-231
24. Inoue T., Saniabadi A.R., Matsunaga R., Hoshi K., Yaguchi I., Morooka S. Impaired endothelium-dependent acetylcholine-induced coronary artery relaxation in patients with high serum remnant lipoprotein particles. Atherosclerosis. 139:1998;363-367
25. McNamara J.R., Shah P.K., Nakajima K., Cupples L.A., Wilson P.W., Ordavas J.M., et al. Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from plasma triglyceride-rich lipoprotein Framingham Heart Study. Atherosclerosis. 154:2001;229-237
26. Takeichi S.N., Nakajima Y., Yukawa N., Saito T., Seto Y., Huang X.L., et al. Association of plasma triglyceride-rich lipoprotein remnants with "Pokkuri Disease" Legal Med. 3:2001;84-94
27. Ichikawa K., Orimo K. Remnant-like particles in various liver diseases. Kitakanto Med. J. 41:1991;159-170. [in Japanese with English summary]
28. Nakajima K., Saito T., Tamura A., Suzuki M., Nakano T., Adachi M. A new assay method for remnant lipoprotein and its clinical significance: 1. The quantification of serum RLP-C (remnant-like particle cholesterol) in a fasting state. J. Jpn. Atheroscler. Soc. 20:1992;79-88. [in Japanese with English summary]
29. Hirany S., O'Byme D., Devaraji S., Jialal I. Remnant-like particle-cholesterol concentrations in patients with type 2 diabetes mellitus and end-stage renal disease. Clin. Chem. 46:2000;667-672
30. Usui S., Jitsukata K., Kazama H., Mizukami Y., Hosaki S., Okazaki M. Simultaneous analysis of serum lipoprotein cholesterol and triglycerides by a HPLC method [Abstract]. Clin. Chem. 46(S):2000;A103
31. Araki A., Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. 422:1987;43-52
32. Sato U., Okuda K. Free glycerol deletion method in TG assay and its clinical application. Rinsho Kensa, Kiki, Shiyaku. 11:1988;97-104. [in Japanese]
33. Sekihara T., Nakano T., Nakajima K. High postprandial plasma remnant-like particles-cholesterol in patients with coronary artery disease on chronic maintenance hemodialysis. Jpn. J. Nephrol. 38:1996;220-228
34. Hamsten A. Hypertriglyceridemia, triglyceride-rich lipoproteins and coronary heart disease. Bailliere's Clin. Endocrinol. Metab. 4:1990;895-922
35. Fontbonne A., Eschwege E., Cambien F., Richard J.L., Ducimetiere P., Thibult N., et al. Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of Paris Prospective Study. Diabetologia. 32:1989;300-304
36. Saniabadi A.R., Takeichi S., Yukawa N., Nakajima Y., Umemura K., Nakashima M. Apo E4/3-rich remnant lipoproteins and platelet aggregation: a case report. Thromb. Haemost. 79:1998;878-879
37. Saniabadi A.R., Umemura K., Adachi M., Nakashima M. Aggregation of human blood platelets by remnant like lipoprotein particles of plasma chylomicrons and very low density lipoproteins. Thromb. Haemost. 77:1997;996-1001
38. Takeichi S. Searching for a new risk factor of sudden cardiac death. Jpn. J. Legal Med. 53:1999;255-275. [English abstract]